Skip to main content
. 2018 Jun 7;8(13):3559–3570. doi: 10.7150/thno.24762

Figure 3.

Figure 3

Schematic representation of the modalities that are currently available to detect PD-1 or PD-L1 expression in tumors, highlighting their advantages (+) and disadvantages (-).